From PCR and CRISPR to autophagy and targeted cancer therapies, scientists share the discoveries that shaped their work and ...
High-content screening combines automated microscopy and quantitative image analysis to measure complex cellular phenotypes ...
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...
Scientist Elizabeth Ng is clutching a small flask with a clear mixture inside it that she’s just retrieved from inside a ...
Hosted on MSN
From stem cell to lifeline: the journey of blood
Your blood is constantly renewed by a hidden army—hematopoietic stem cells in your bone marrow. These cells can create every type of blood cell, but new research shows some are surprisingly picky, ...
Qkine-PLSX Pluristyx and Qkine Announce Strategic Partnership SEATTLE and CAMBRIDGE, United Kingdom, May 01, 2026 (GLOBE ...
Pluristyx, a leading provider of clinical-grade induced pluripotent stem cell (iPSC) solutions, and Qkine, a pioneer in the manufacture ...
American scientists have announced plans to resurrect an extinct antelope species using Jurassic Park technology.
NYBCe and CZ Biohub will derive iPSC lines from cord blood's immune cells, creating shared, broadly compatible resources for cell therapy, disease modelling, and AI-driven drug development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results